Skip to content
EU Parl Watch

opinion parliamentary committee, 15 September 2025

General budget of the European Union for the financial year 2026 – all sections

Document SANT-AD-775468 · (2025/0210(BUD))

Committee on Public Health · Rapporteur: Michalis Hadjipantela

On Parliament’s site PDF Word

AI:In short

The Committee on Public Health calls on the Committee on Budgets to incorporate its suggestions into the 2026 EU budget resolution, focusing on strengthening public health systems, increasing funding for key health initiatives, and addressing health inequalities. It demands adequate funding for prevention, mental health, digital health, research, and preparedness, while opposing cuts to EU4Health and Horizon Europe health research. It also calls for aligning cohesion funds with health objectives, supporting cross-border care, and ensuring transparent, result-oriented spending.

Key points

  1. Calls for practical solutions to build stronger, more resilient, accessible, and affordable public health systems, with adequate resources for implementing key health legislation.
  2. Urges recognition of public health as a sector of strategic autonomy, prioritizing investments in underserved regions and addressing social determinants of health.
  3. Calls for alignment of national recovery and cohesion funding with EU health objectives, including investments in local infrastructure, stockpiles, and training.
  4. Highlights the need for global health cooperation with WHO and welcomes the Commission's preparedness strategy for future health threats.
  5. Welcomes the proposed 17.6% increase in EU4Health budget for 2026 but regrets the Council's proposed cut of €97.3 million, calling for an agreement that increases the draft budget allocation.
  6. Stresses that decreases in the Cohesion Fund harm health-related categories and calls for a targeted EU programme to improve access to health and telemedicine in remote regions.
  7. Calls for transparent, result-oriented spending with focus on mental health, digital health, AMR, and non-communicable diseases, and for synergies with ESF+ for upskilling healthcare professionals.
  8. Underlines the need for dedicated funding to combat AMR and to improve working conditions and retention of healthcare professionals, especially in underserved areas.
  9. Reiterates the importance of cross-border healthcare and patient mobility, calling for increased funding for interoperability of national health systems.
  10. Calls for budget lines for digital transformation in health, including AI and robotics, with a human dimension and focus on children.
  11. Emphasizes the need for funding and regulatory support for innovative medical technologies, stockpiling, joint procurement, and crisis preparedness.
  12. Commends progress of Europe's Beating Cancer Plan and calls for prioritising childhood cancer support, tackling health disinformation, and supporting European Reference Networks.

Who is affected

  • Member states and the Commission, which must allocate resources and implement health priorities.
  • Healthcare professionals, who need better working conditions, training, and retention measures.
  • Patients, particularly those needing cross-border care, transplants, and access to innovative treatments.
  • Small and medium-sized enterprises and start-ups in health and biotechnology, which need support for innovation.
  • Civil society organisations and NGOs working on health, which need adequate and predictable funding.

Figures and deadlines

  • 17.6% increase in the EU4Health budget for 2026 compared to 2025.
  • €97.3 million cut proposed by the Council to EU4Health.

Written by AI from the full text · every figure comes from the text · ¶ opens the paragraph · 4 Sept 2026 · Report a problem

Full text

Opinion 23 paragraphs

The Committee on Public Health calls on the Committee on Budgets, as the committee responsible, to incorporate the following into its motion for a resolution:

1. Calls on the Commission, Member States and relevant stakeholders to urgently identify practical solutions to build stronger, more resilient, more competitive, more accessible, and more affordable public health systems; stresses the need to allocate adequate human and financial resources to swiftly implement legislation in the areas of public health, focusing on several key priorities like the successful implementation of the European Health Data Space (EHDS), Europe’s Beating Cancer Plan, the Healthier Together Initiative, the Comprehensive Approach to Mental Health, the EU Research Mission on Cancer, the Action Plan on the Cybersecurity of Hospitals and Health Systems, the forthcoming Critical Medicines Act, the General Pharmaceutical Law, the European Preparedness Union Strategy and the Medical Countermeasures Strategy, the Biotech Act, the Clinical Trials regulation, the AICare@EU and the One Health approach, in order to set strong foundations for a European Health Union, in line with Member States’ competences, and revitalise innovation sectors to better meet patient needs, promote preventive care and drive lasting impact;

2. Calls on the Commission to ensure that public health systems are duly recognised as a sector of strategic autonomy and security within Union funding frameworks; highlights that investments in public health infrastructure should prioritise underserved regions and social backgrounds, reducing disparities in access; calls for adequate funding for measures addressing social determinants of health, such as poverty, housing, education and food security, to reduce health inequalities and improve overall well-being;

3. Calls for the alignment of national recovery and cohesion funding with EU health objectives, supporting investments in resilient local health infrastructure, stockpiles, and training for frontline workers; identifies the importance of introducing mental health education and early prevention and diagnosis in school curricula; stresses that adequate funding should be allocated to prevention, vaccination and life-course immunisation; stresses the growing public health challenge of climate change; highlights that EU funding for climate adaptation should systematically integrate health-related risks, particularly those linked to extreme weather events, air quality, and vector-borne diseases;

4. Highlights the importance of enhancing the Union’s global role with the appropriate funding for initiatives that address public health globally, including the cooperation with the World Health Organisation (WHO) and global partners , including advancing the EU and WHO goals, and jointly securing UN Sustainable Development Goals, in regard to public health; welcomes the Commission's strategy for preparedness and response to future health threats, which focuses on a more stringent surveillance, on early warning and coordination between Member States;

5. Welcomes the proposed 17.6% increase in the EU4Health budget for 2026, compared to 2025 figures; stresses that this increase remains below the levels agreed in the MFF prior to the mid-term review; regrets that the Council proposed a cut of €97.3 million; calls for an agreement that increases the draft budget allocation for the EU4Health Programme; reiterates that this level is insufficient to meet the Union’s growing public health needs, increased demographic pressures and the programme’s core objectives, supporting actions that enhance the availability, accessibility and affordability of medicinal products, medical devices and crisis-relevant products;

6 Notes that strengthening Europe’s brain capital is essential to mitigate productivity losses, foster resilience and ensure long-term innovation capacity; reiterates the importance of a substantial increase in healthcare funding and the full execution of the budget lines, ensuring that resources reach beneficiary Member States and support tangible improvements to public health; recalls that the Draghi Report highlights that current EU programmes are underfunded, bureaucratic, and that fragmented spending and duplication of efforts undermines their impact and effectiveness; considers that the proposed funding for the Critical Medicines Act can hinder the effectiveness of the proposal;

7. Stresses that the decreases in the Cohesion Fund have a detrimental effect in the health related categories covering services, infrastructure, equipment, digitalisation and resilience, with a substantially negative effect for regions and communities who receive the funds; calls on the Commission to develop and fund a targeted EU programme to improve access to health, as well as telemedicine services for remote, rural, and mountainous, island and outermost regions, supporting mobile health units, local telemedicine hubs, and incentives for medical staff, with particular attention to addressing existing health inequalities between Eastern and Western Member States, and ensuring fair distribution of resources in regions facing structural disadvantages;

8 Calls for the alignment of national recovery and cohesion funding with EU health preparedness objectives, supporting investments in resilient local health infrastructure, stockpiles, and training for frontline workers; encourages the mobilisation of additional resources through alternative channels; calls on the Commission to mainstream public health objectives across budgetary instruments and funds, establishing health as a transversal investment priority within the MFF; calls for strict conditionality to ensure EU4Health funds are directed to investments that benefit public health, including strengthening sexual and reproductive health.

9. Stresses the need for transparent, result-oriented public health spending, with a focus on mental health, and neurological disorders, digital health, AMR, zoonotic diseases, and non-communicable diseases, such as cardiovascular diseases, rare diseases and cancer, primary care, promotion of healthy lifestyles and investment in the health workforce, including targeted support for digital upskilling; highlights that regular reporting of key performance indicators is needed to increase the accountability and transparency of the EU budget; calls for synergies with the ESF+ programme to upskill and reskill healthcare professionals, especially in digital tools and community-based care models;

10. Underlines that combating AMR requires dedicated funding to support research into modern, innovative solutions; emphasizes that investing in high-quality public healthcare systems, including effective infection prevention and control measures, diagnostics, working conditions, clinical competencies, and accessibility awareness for the health workforce are key to reducing health inequalities across the Union;

11. Recalls the conclusions of the WHO report “Health and care workforce in Europe: time to act”, that mobility of health professionals should not be at the detriment of already understaffed areas; calls on the Commission to ensure the retention of healthcare professionals through targeted incentives, professional development opportunities and concrete measures to attract and support healthcare workers, particularly in underserved areas such as rural, remote and outermost regions; stresses the urgent need to improve the working conditions of healthcare professionals; underlines the crucial need to support the prompt training of new health professionals, including it as a priority to ESF+ and cohesion funds; calls for increased funding and targeted measures to improve access to high-quality healthcare services, innovative treatments for cardiovascular diseases, cancer, mental health conditions, rare diseases, and digital healthcare solutions , including early diagnosis, treatment of paediatric diseases, mental health support, and promotion of child-specific preventive care, including mental health programmes ; calls for the allocation of specific budget lines in this regard, including training of mental health professionals, development of evidence-based prevention curricula and provision of digital tools for early detection and intervention, including the expansion of school and university-based mental health services and trainings;

Read the rest (11 paragraphs)

12. Reiterates the importance of cross-border accessible and affordable health care, cross-border mobility of patients, particularly transplant patients, as well as the mobility of health professionals and coordinated pandemic response mechanisms across the EU, and with co-operation with global partners; calls for increased funding for interoperability and interconnection of national health systems for the benefit of patients’ mobility;

13. Calls for budget lines to support the digital transformation in health, including robotic and AI innovation in diagnostics and treatments in care, which should include a strong human dimension, with a particular focus on children;

14. Emphasizes the need for targeted funding and regulatory support for the development, approval, and uptake of innovative medical technologies, including medical devices and in vitro diagnostics; highlights the need for dedicated funding for stockpiling, joint procurement, support for health system reform, a shift towards preventable health systems, rapid response mechanisms, crisis preparedness and disease prevention to address strategic vulnerabilities; highlights the importance of the EU Preparedness Strategy, which requires sufficient funding and operational capacity support from relevant agencies in order to strengthen detection and identification of health threats and stimulate crucial innovation in research, development and production of medical countermeasures;

15. Commends the ongoing progress of Europe’s Beating Cancer Plan and the EU Research Mission on Cancer and suggests the update of key performance indicators for its implementation across member states; calls for the 2026 budget to prioritise EU support for childhood cancer and to sustain progress and support continuation of high value cross-border cancer projects, such as the EU cancer survivor smartcard; recognises the increase of health-related disinformation, therefore calls for funding initiatives that tackle disinformation and support digital skills and health literacy; calls for increased and sustained support for the European Reference Networks (ERNs) and strengthening clinical collaboration across Member States;

16. Calls for targeted EU funding to support the implementation of the psychosocial approach to mental health based on human rights and recovery, with a strong focus on young people and children; highlights the need to integrate mental health priorities across EU4Health, Horizon Europe, and related programmes; stresses that funding must reflect the urgency of the youth mental health crisis, including challenges stemming from the online environment;

17. Stresses that the proposed reductions to the cluster “Health” of Horizon Europe, supported by the Council, will have a detrimental effect on the research and innovation for health, including the development and manufacturing of biotechnologies and advanced neuroscience solutions, severely impacting European research excellence, competitiveness, strategic autonomy, treatment gap and the quality of healthcare provided as a result of the research; calls for the increase of these appropriations to reflect the commitment of the European Commission in maintaining the European Union’s leadership in academic research and ground-breaking health innovation, protecting the European manufacturing and skills base; stresses the importance of coherence between legislation and funding, so as to reduce barriers to entry, and strengthen the internal market;

18. Recalls that the Draghi Report proposes the doubling of the EU research and innovation budget, specifically to boost competitiveness, health innovation, and resilience; highlights the findings of the Letta Report on a resilient European healthcare sector, calling on the EU to act decisively to foster integration, research, collaboration and strategic autonomy in healthcare and pharmaceuticals, and reduce dependency on third countries for critical supply chains, by investing in self-sufficiency, joint procurement, and supply chain security; underlines that such reductions in research and innovation have a particularly devastating impact on small and medium-sized enterprises (SMEs) and start-ups , which are key drivers of innovation in health and biotechnology—sectors that form a fundamental pillar of European competitiveness and its ability to deliver high-quality healthcare for all;

19. Calls for increased investment in advanced therapeutic approaches, including gene and cell therapies, to address unmet medical needs; underlines the importance of strengthening the EU’s capacity for research, clinical trials, manufacturing, and equitable access to these innovative treatments, ensuring a fair return of public investment on patient outcome; proposes that InvestEU includes a public health investment programme, to attract private and public co-financing for medical innovation, cross-border health infrastructure and digital solutions;

20. Stresses that the increasingly unstable geopolitical situation highlights that preparedness and response to public health threats should be an essential part of the EU Security and Defence plan; highlights the benefits of synergies between partnerships and investments; Recognises the importance of taking into account the healthcare sector’s preparedness for external threats, as highlighted in the Niinistö report; underlines that, in the event of a military or security crisis, the healthcare sector plays a critical role in ensuring medical assistance, emergency response, and civilian protection; recalls for the inclusion of adequate and dedicated funding to strengthen the preparedness and resilience of healthcare systems, including infrastructure, civil–military coordination, medical supplies, human resources, and emergency response capacities; calls for dedicated support for the scale-up of health-related SMEs, especially those active in medical technology;

21. Recognises that the increase in the commitment appropriations of the European Medicines Agency, the European Agency for Safety and Health at Work and the European Centre for Disease Prevention and Control merely cover the effects of inflation, and do not reflect an investment in upgrading their services and operational capabilities; calls for adequate, and a better allocation of funding based on the operational programme and directives of these agencies; highlights the importance of effectively allocating appropriate human and financial resources to all relevant DGs and agencies; calls for further support for the digital and operational upgrading of these agencies to ensure full coordination, especially during health emergencies;

22. Calls for the adequate and predictable funding of health related civil society organisations and NGOs, particularly those working on information, prevention, patient representation and patient care; highlights the need to safeguard the role of stakeholders in meeting and accelerating public health needs with transparent and unbiased procedures to ensure a regular dialogue with EU institutions, contributing to democratic participation in health policy.

Annex: declaration of input 1 paragraph

The rapporteur for opinion declares under his exclusive responsibility that he did not include in his opinion input from interest representatives falling within the scope of the Interinstitutional Agreement on a mandatory transparency register, or from representatives of public authorities of third countries, including their diplomatic missions and embassies, to be listed in this Annex pursuant to Article 8 of Annex I to the Rules of Procedure.

Information on adoption by the committee asked for opinion 1 paragraph
Date adopted1.9.2025
Result of final vote+: –: 0:27 4 1
Members present for the final voteChristine Anderson, Vytenis Povilas Andriukaitis, Bartosz Arłukowicz, Stine Bosse, Marie-Luce Brasier-Clain, Laurent Castillo, Veronika Cifrová Ostrihoňová, Christophe Clergeau, Margarita de la Pisa Carrión, Viktória Ferenc, Michalis Hadjipantela, Gerald Hauser, Martin Häusling, Adam Jarubas, András Tivadar Kulja, Peter Liese, Tilly Metz, Alessandra Moretti, Victor Negrescu, Nikos Papandreou, Oliver Schenk, Tomislav Sokol, Vlad Vasile-Voiculescu
Substitutes present for the final voteSebastian Everding, Tomáš Kubín, Liesbet Sommen, Nicolae Ștefănuță, Marta Temido, Ingeborg Ter Laak, Kristian Vigenin
Members under Rule 216(7) present for the final voteDan Barna, Dimitris Tsiodras, Marion Walsmann

Procedure pages

How the committees handled the text, and how their members voted on it.

Final vote by roll call by the committee asked for opinion 3 paragraphs

27 · For

EPP
Bartosz Arłukowicz, Laurent Castillo, Michalis Hadjipantela, Adam Jarubas, András Tivadar Kulja, Peter Liese, Oliver Schenk, Tomislav Sokol, Liesbet Sommen, Ingeborg Ter Laak, Dimitris Tsiodras
Patriots
Viktória Ferenc, Tomáš Kubín
Renew
Dan Barna, Stine Bosse, Veronika Cifrová Ostrihoňová
S&D
Vytenis Povilas Andriukaitis, Christophe Clergeau, Alessandra Moretti, Victor Negrescu, Nikos Papandreou, Marta Temido, Kristian Vigenin
The Left
Sebastian Everding
Greens
Martin Häusling, Tilly Metz, Nicolae Ștefănuță

4 · Against

ESN
Christine Anderson
Patriots
Gerald Hauser, Margarita de la Pisa Carrión
Renew
Vlad Vasile-Voiculescu

1 · Abstained

Patriots
Marie-Luce Brasier-Clain